Reuters - The Novartis osteoporosis drug Reclast,
given once a year, reduces the risk of broken bones for three
years but may spark an abnormal heart rhythm in some patients,
researchers said on Wednesday.
Source: http://rss.news.yahoo.com
Thursday, May 3, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment